Cargo Therapeutics Q4 2023 GAAP EPS $(1.49) Misses $(1.44) Estimate
Portfolio Pulse from Benzinga Newsdesk
Cargo Therapeutics (NASDAQ:CRGX) reported a Q4 2023 GAAP EPS of $(1.49), missing the consensus estimate of $(1.44) by 3.47%.
March 21, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cargo Therapeutics reported a Q4 2023 GAAP EPS of $(1.49), missing the consensus estimate of $(1.44) by 3.47%.
Missing earnings estimates typically leads to negative investor sentiment in the short term, potentially causing a decrease in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100